Literature DB >> 11087041

Evaluation of a human bio-engineered skin equivalent for drug permeation studies.

C Asbill1, N Kim, A El-Kattan, K Creek, P Wertz, B Michniak.   

Abstract

PURPOSE: To test the barrier function of a bio-engineered human skin (BHS) using three model drugs (caffeine, hydrocortisone, and tamoxifen) in vitro. To investigate the lipid composition and microscopic structure of the BHS.
METHODS: The human skin substitute was composed of both epidermal and dermal layers, the latter having a bovine collagen matrix. The permeability of the BHS to three model drugs was compared to that obtained in other percutaneous testing models (human cadaver skin, hairless mouse skin, and EpiDerm). Lipid analysis of the BHS was performed by high performance thin layered chromatography. Histological evaluation of the BHS was performed using routine H&E staining.
RESULTS: The BHS mimicked human skin in terms of lipid composition, gross ultrastructure, and the formation of a stratum corneum. However, the permeability of the BHS to caffeine, hydrocortisone, and tamoxifen was 3-4 fold higher than that of human cadaver skin.
CONCLUSIONS: In summary, the results indicate that the BHS may be an acceptable in vitro model for drug permeability testing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087041     DOI: 10.1023/a:1026405712870

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  Barrier function of human keratinocyte cultures grown at the air-liquid interface.

Authors:  V H Mak; M B Cumpstone; A H Kennedy; C S Harmon; R H Guy; R O Potts
Journal:  J Invest Dermatol       Date:  1991-03       Impact factor: 8.551

Review 2.  Tissue engineered skin: Apligraf, a bi-layered living skin equivalent.

Authors:  J F Trent; R S Kirsner
Journal:  Int J Clin Pract       Date:  1998-09       Impact factor: 2.503

3.  New skin for old: developments in biological skin substitutes.

Authors:  T J Phillips
Journal:  Arch Dermatol       Date:  1998-03

4.  Bioengineered skin.

Authors:  M Muhart; S McFalls; R Kirsner; F Kerdel; W H Eaglstein
Journal:  Lancet       Date:  1997-10-18       Impact factor: 79.321

5.  Percutaneous penetration enhancement activity of aromatic S, S-dimethyliminosulfuranes.

Authors:  N Kim; M El-Khalili; M M Henary; L Strekowski; B B Michniak
Journal:  Int J Pharm       Date:  1999-10-05       Impact factor: 5.875

6.  Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness.

Authors:  E Bell; H P Ehrlich; D J Buttle; T Nakatsuji
Journal:  Science       Date:  1981-03-06       Impact factor: 47.728

7.  Mechanism of percutaneous absorption. 3. The effect of temperature on the transport of non-electrolytes across the skin.

Authors:  I H Blank; R J Scheuplein; D J MacFarlane
Journal:  J Invest Dermatol       Date:  1967-12       Impact factor: 8.551

8.  Acylglucosylceramides of pig epidermis: structure determination.

Authors:  P W Wertz; D T Downing
Journal:  J Lipid Res       Date:  1983-06       Impact factor: 5.922

9.  Glucosylceramides of pig epidermis: structure determination.

Authors:  P W Wertz; D T Downing
Journal:  J Lipid Res       Date:  1983-09       Impact factor: 5.922

10.  Lipid content and water permeability of skin and oral mucosa.

Authors:  C A Squier; P Cox; P W Wertz
Journal:  J Invest Dermatol       Date:  1991-01       Impact factor: 8.551

View more
  9 in total

1.  Integrated multimodal optical microscopy for structural and functional imaging of engineered and natural skin.

Authors:  Youbo Zhao; Benedikt W Graf; Eric J Chaney; Ziad Mahmassani; Eleni Antoniadou; Ross Devolder; Hyunjoon Kong; Marni D Boppart; Stephen A Boppart
Journal:  J Biophotonics       Date:  2012-02-27       Impact factor: 3.207

Review 2.  Xenobiotic bioconversion in human epidermis models.

Authors:  Audra L Stinchcomb
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

3.  Effects of growth conditions on the barrier properties of a human skin equivalent.

Authors:  Priya Batheja; Yifan Song; Philip Wertz; Bozena Michniak-Kohn
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

4.  Skin-on-a-chip model simulating inflammation, edema and drug-based treatment.

Authors:  Maierdanjiang Wufuer; GeonHui Lee; Woojune Hur; Byoungjun Jeon; Byung Jun Kim; Tae Hyun Choi; SangHoon Lee
Journal:  Sci Rep       Date:  2016-11-21       Impact factor: 4.379

Review 5.  Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin.

Authors:  Saurabh Dixit; Dieudonné R Baganizi; Rajnish Sahu; Ejowke Dosunmu; Atul Chaudhari; Komal Vig; Shreekumar R Pillai; Shree R Singh; Vida A Dennis
Journal:  J Biol Eng       Date:  2017-12-13       Impact factor: 4.355

6.  Bioengineering of a Full-Thickness Skin Equivalent in a 96-Well Insert Format for Substance Permeation Studies and Organ-On-A-Chip Applications.

Authors:  Katharina Schimek; Hao-Hsiang Hsu; Moritz Boehme; Jacob Jan Kornet; Uwe Marx; Roland Lauster; Ralf Pörtner; Gerd Lindner
Journal:  Bioengineering (Basel)       Date:  2018-06-07

Review 7.  Advances in the Biofabrication of 3D Skin in vitro: Healthy and Pathological Models.

Authors:  Matthew J Randall; Astrid Jüngel; Markus Rimann; Karin Wuertz-Kozak
Journal:  Front Bioeng Biotechnol       Date:  2018-10-31

8.  Design of an Integrated Microvascularized Human Skin-on-a-Chip Tissue Equivalent Model.

Authors:  Christian F E Jones; Stefania Di Cio; John T Connelly; Julien E Gautrot
Journal:  Front Bioeng Biotechnol       Date:  2022-07-19

Review 9.  Modeling an Optimal 3D Skin-on-Chip within Microfluidic Devices for Pharmacological Studies.

Authors:  Estibaliz Fernandez-Carro; Maricke Angenent; Tamara Gracia-Cazaña; Yolanda Gilaberte; Clara Alcaine; Jesús Ciriza
Journal:  Pharmaceutics       Date:  2022-07-06       Impact factor: 6.525

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.